Literature DB >> 6429399

Combined cytotoxic and endocrine therapy for human breast carcinoma (Br-10) serially transplanted into nude mice.

T Kubota, K Kubouchi, J Koh, F Asanuma, K Enomoto, K Ishibiki, O Abe.   

Abstract

Cytotoxic and endocrine therapy on a human breast carcinoma (Br-10) serially transplanted into nude mice was given with reference to the sequence of drug administration. Mitomycin C (MMC) was combined with 2.5 mg/kg of tamoxifen (TAM). MMC was dissolved in 0.2 ml of physiological saline and administered intraperitoneally once weekly. TAM was dissolved in 0.1 ml of sesame oil and administered intramuscularly twice weekly. Both drugs were administered in the reverse sequence for 2 or 3 weeks. Cytosol estrogen receptor (ERc), nuclear estrogen receptor (ERn) and progesterone receptor (PgR), and 3H-thymidine uptake labeling index (L.I.) were assayed after the treatment. When 1.5 mg/kg of MMC was combined with TAM, statistically significant differences were nil between the different sequential administrations. When the MMC administration was reduced to 0.75 mg/kg and 2 weeks, respectively, the MMC----TAM sequence was more effective than the reversed sequential administration. MMC preserved ERc and depressed L.I. to almost half of that of the control tumor. TAM generated the ER systems and slightly depressed L.I. These different modes of action between MMC and TAM on ER systems and L.I. may explain the antitumor effects of different sequential administrations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429399     DOI: 10.1007/bf02469607

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  10 in total

1.  Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice.

Authors:  S Hirohashi; Y Shimosato; T Kameya; K Nagai; R Tsunematsu
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

2.  Similarity of the estrogen receptor in human and rat mammary carcinoma.

Authors:  W L McGuire; M DeLaGarza
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

3.  Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-04-10       Impact factor: 5.157

4.  Histologic changes following oestradiol treatment of a hormone-responsive human breast carcinoma grown in nude mice.

Authors:  N Brünner; J Visfeldt
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1982-09

5.  Chemotherapy of a human malignant melanoma transplanted in the nude mouse.

Authors:  C O Povlsen; G K Jacobsen
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

6.  [Effect of mitomycin C on human gastric and colon carcinomas serially transplanted to nude mice--with special reference to the start of drug administration].

Authors:  T Kubota; Y Hanatani; K Tsuyuki; M Nakada; F Asanuma; K Ishibiki; O Abe
Journal:  Gan To Kagaku Ryoho       Date:  1982-04

7.  Antitumor effect and metabolic activation of cyclophosphamide and 4-hydroperoxycyclophosphamide in the human breast carcinoma (MX-1)-nude mouse system.

Authors:  T Kubota; Y Hanatani; K Tsuyuki; M Nakada; K Ishibiki; O Abe; T Kamataki; R Kato
Journal:  Gan       Date:  1983-06

8.  Transplantation of human tumors in nude mice.

Authors:  Y Shimosato; T Kameya; K Nagai; S Hirohashi; T Koide; H Hayashi; T Nomura
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

9.  Human breast carcinoma (MCF-7) serially transplanted into nude mice.

Authors:  T Kubota; K Kubouchi; J Koh; K Enomoto; K Ishibiki; O Abe
Journal:  Jpn J Surg       Date:  1983-07

10.  Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice.

Authors:  S M Shafie; F H Grantham
Journal:  J Natl Cancer Inst       Date:  1981-07       Impact factor: 13.506

  10 in total
  1 in total

1.  Changes in the hormone receptors of human breast carcinoma xenografts in nude mice by treatment with cytotoxic agents.

Authors:  J Koh; E Shiina; Y Hosoda; M Hashimoto; O Yamamoto; S Sakai; T Kubota; K Enomoto; O Abe
Journal:  Jpn J Surg       Date:  1990-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.